BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38895305)

  • 21. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
    Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A
    Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo differentiation of adult hematopoietic stem cells from a single-cell point of view.
    Nazaraliyev A; Richard E; Sawai CM
    Curr Opin Hematol; 2020 Jul; 27(4):241-247. PubMed ID: 32398457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External signals regulate continuous transcriptional states in hematopoietic stem cells.
    Fast EM; Sporrij A; Manning M; Rocha EL; Yang S; Zhou Y; Guo J; Baryawno N; Barkas N; Scadden D; Camargo F; Zon LI
    Elife; 2021 Dec; 10():. PubMed ID: 34939923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.
    Akhtar S; Rauf MS; Elhassan TAM; Khan ZA; Elshenawy MA; Maghfoor I
    Transplant Cell Ther; 2023 Jul; 29(7):451.e1-451.e12. PubMed ID: 37031748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience.
    Mediwake H; Morris K; Curley C; Butler J; Kennedy G
    Intern Med J; 2017 May; 47(5):574-578. PubMed ID: 28247950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
    Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
    Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.
    Richter S; Böttcher M; Stoll A; Zeremski V; Völkl S; Mackensen A; Ekici AB; Jacobs B; Mougiakakos D
    Transplant Cell Ther; 2024 Jun; 30(6):628.e1-628.e9. PubMed ID: 38460727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases.
    Al-toma A; Nijeboer P; Bouma G; Visser O; Mulder CJ
    World J Gastroenterol; 2014 Dec; 20(46):17368-75. PubMed ID: 25516648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell transplantation as rescue therapy for refractory Crohn's disease: a sytematic review.
    Labidi A; Serghini M; Ben Mustapha N; Fekih M; Boubaker J; Filali A
    Tunis Med; 2014 Nov; 92(11):655-9. PubMed ID: 25867145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cadmium modulates hematopoietic stem and progenitor cells and skews toward myelopoiesis in mice.
    Zhang Y; Yu X; Sun S; Li Q; Xie Y; Li Q; Zhao Y; Pei J; Zhang W; Xue P; Zhou Z; Zhang Y
    Toxicol Appl Pharmacol; 2016 Dec; 313():24-34. PubMed ID: 27771405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.
    Müller AM; Florek M; Kohrt HE; Küpper NJ; Filatenkov A; Linderman JA; Hadeiba H; Negrin RS; Shizuru JA
    J Immunol; 2016 Nov; 197(10):4151-4162. PubMed ID: 27815446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
    Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
    J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
    Hosing C; Saliba RM; McLaughlin P; Andersson B; Rodriguez MA; Fayad L; Cabanillas F; Champlin RE; Khouri IF
    Ann Oncol; 2003 May; 14(5):737-44. PubMed ID: 12702528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease.
    McDonald GB; Landsverk OJB; McGovern DPB; Aasebø A; Paulsen V; Haritunians T; Reims HM; McLaughlin BM; Zisman T; Li D; Elholm ETMM; Jahnsen FL; Georges GE; Gedde-Dahl T
    Heliyon; 2024 Jan; 10(1):e24026. PubMed ID: 38283244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.
    Lum LG; Thakur A; Liu Q; Deol A; Al-Kadhimi Z; Ayash L; Abidi MH; Pray C; Tomaszewski EN; Steele PA; Schalk DL; Yano H; Mitchell A; Dufresne M; Uberti JP; Ratanatharathorn V
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):925-33. PubMed ID: 23529012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
    Merryman RW; Redd R; Jeter E; Wong JL; McHugh K; Reynolds C; Nazzaro M; Varden A; Brown JR; Crombie JL; Davids MS; Fisher DC; Jacobsen E; Jacobson CA; Kim AI; LaCasce AS; Ng SY; Odejide OO; Parry EM; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Ritz J
    Transplant Cell Ther; 2022 Jan; 28(1):32.e1-32.e10. PubMed ID: 34670169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case Report.
    Kamachi K; Ando T; Tsuruoka N; Hashiguchi M; Kidoguchi K; Kusaba K; Sano H; Sano H; Yamaguchi K; Nishioka A; Yoshimura M; Yokoo M; Kubota Y; Kojima K; Kimura S
    Tohoku J Exp Med; 2020 Jun; 251(2):81-85. PubMed ID: 32507783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.